Trial · NCT01414075
Results by group258
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 258
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Maximum Change From Baseline in Hb During Weeks 3-13 | Arm A + E (Participants on HD): Roxadustat Only, No Iron | Baseline | 8.1 | Standard Error 0.2 | grams/deciliter (g/dL) |
| Maximum Change From Baseline in Hb During Weeks 3-13 | Arm B (Participants on HD): PO Iron (Ferrous Fumarate or Ferrous Gluconate) Between 50 and 195 mg | Baseline | 8.5 | Standard Error 0.3 | grams/deciliter (g/dL) |
| Maximum Change From Baseline in Hb During Weeks 3-13 | Arm C (Participants on HD): IV Iron (Ferric Gluconate Complex in Sucrose or Equivalent) 60 mg | Baseline | 8.4 | Standard Error 0.3 | grams/deciliter (g/dL) |
| Maximum Change From Baseline in Hb During Weeks 3-13 | Arm D (Participants on PD): PO Iron (Ferrous Fumarate or Ferrous Gluconate) Between 50 and 195 mg | Baseline | 8.7 | Standard Error 0.2 | grams/deciliter (g/dL) |
| Maximum Change From Baseline in Hb During Weeks 3-13 | Arm A + E (Participants on HD): Roxadustat Only, No Iron | Change at Weeks 3-13 | 2.8 | Standard Error 0.2 | grams/deciliter (g/dL) |
| Maximum Change From Baseline in Hb During Weeks 3-13 | Arm B (Participants on HD): PO Iron (Ferrous Fumarate or Ferrous Gluconate) Between 50 and 195 mg | Change at Weeks 3-13 | 3.5 | Standard Error 0.5 | grams/deciliter (g/dL) |
| Maximum Change From Baseline in Hb During Weeks 3-13 | Arm C (Participants on HD): IV Iron (Ferric Gluconate Complex in Sucrose or Equivalent) 60 mg | Change at Weeks 3-13 | 3.5 | Standard Error 0.4 | grams/deciliter (g/dL) |
| Maximum Change From Baseline in Hb During Weeks 3-13 | Arm D (Participants on PD): PO Iron (Ferrous Fumarate or Ferrous Gluconate) Between 50 and 195 mg | Change at Weeks 3-13 | 3.3 | Standard Error 0.2 | grams/deciliter (g/dL) |
| Mean Change From Baseline in Hb During Weeks 2-5, 6-9, and 10-13 | Arm A + E (Participants on HD): Roxadustat Only, No Iron | Baseline | 8.1 | Standard Error 0.2 | g/dL |
| Mean Change From Baseline in Hb During Weeks 2-5, 6-9, and 10-13 | Arm B (Participants on HD): PO Iron (Ferrous Fumarate or Ferrous Gluconate) Between 50 and 195 mg | Baseline | 8.5 | Standard Error 0.3 | g/dL |
| Mean Change From Baseline in Hb During Weeks 2-5, 6-9, and 10-13 | Arm C (Participants on HD): IV Iron (Ferric Gluconate Complex in Sucrose or Equivalent) 60 mg | Baseline | 8.4 | Standard Error 0.3 | g/dL |
| Mean Change From Baseline in Hb During Weeks 2-5, 6-9, and 10-13 | Arm D (Participants on PD): PO Iron (Ferrous Fumarate or Ferrous Gluconate) Between 50 and 195 mg | Baseline | 8.7 | Standard Error 0.2 | g/dL |
| Mean Change From Baseline in Hb During Weeks 2-5, 6-9, and 10-13 | Arm A + E (Participants on HD): Roxadustat Only, No Iron | Change at Weeks 2-5 | 1.1 | Standard Error 0.1 | g/dL |
| Mean Change From Baseline in Hb During Weeks 2-5, 6-9, and 10-13 | Arm B (Participants on HD): PO Iron (Ferrous Fumarate or Ferrous Gluconate) Between 50 and 195 mg | Change at Weeks 2-5 | 1.1 | Standard Error 0.2 | g/dL |
| Mean Change From Baseline in Hb During Weeks 2-5, 6-9, and 10-13 | Arm C (Participants on HD): IV Iron (Ferric Gluconate Complex in Sucrose or Equivalent) 60 mg | Change at Weeks 2-5 | 1.0 | Standard Error 0.2 | g/dL |
| Mean Change From Baseline in Hb During Weeks 2-5, 6-9, and 10-13 | Arm D (Participants on PD): PO Iron (Ferrous Fumarate or Ferrous Gluconate) Between 50 and 195 mg | Change at Weeks 2-5 | 0.8 | Standard Error 0.3 | g/dL |
| Mean Change From Baseline in Hb During Weeks 2-5, 6-9, and 10-13 | Arm A + E (Participants on HD): Roxadustat Only, No Iron | Change at Weeks 6-9 | 2.0 | Standard Error 0.2 | g/dL |
| Mean Change From Baseline in Hb During Weeks 2-5, 6-9, and 10-13 | Arm B (Participants on HD): PO Iron (Ferrous Fumarate or Ferrous Gluconate) Between 50 and 195 mg | Change at Weeks 6-9 | 2.3 | Standard Error 0.4 | g/dL |
| Mean Change From Baseline in Hb During Weeks 2-5, 6-9, and 10-13 | Arm C (Participants on HD): IV Iron (Ferric Gluconate Complex in Sucrose or Equivalent) 60 mg | Change at Weeks 6-9 | 2.0 | Standard Error 0.4 | g/dL |
| Mean Change From Baseline in Hb During Weeks 2-5, 6-9, and 10-13 | Arm D (Participants on PD): PO Iron (Ferrous Fumarate or Ferrous Gluconate) Between 50 and 195 mg | Change at Weeks 6-9 | 1.8 | Standard Error 0.4 | g/dL |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01414075/results